Literature DB >> 24751654

Imaging of naive myopic choroidal neovascularization by spectral-domain optical coherence tomography.

Paolo Milani1, Alfredo Pece, Luisa Pierro, Fulvio Bergamini.   

Abstract

PURPOSE: To assess the tomographic features of myopic choroidal neovascularization by spectral-domain optical coherence tomography.
METHODS: We consecutively reviewed the charts of patients with pathologic myopia, recent visual acuity deterioration and active macular neovascularization. Specific tomographic changes were studied in 25 eyes by two authors independently.
RESULTS: The mean age of patients eligible for the study was 63.4 (± 18.2) years. Main tomographic outcomes were the hyperreflectivity of the lesion in 88% of cases (95% CI 0.74-1.02), absence of the external limiting membrane in 88% (95% CI 0.84-1.02), and retinal thickening in 83% (95% CI 0.67-0.99). The internal plexiform layer remained discernible in 83% (95% CI 0.67-0.99) of cases, the inner nuclear layer in 62% (95% CI 0.37-0.80), the external plexiform layer in 48% (95% CI 0.27-0.69). Retinal edema was noted in 48% (95% CI 0.26-0.70) of patients.
CONCLUSIONS: Myopic choroidal neovascularization appears predominantly hyperreflective, causes thickening of the corresponding retina and mainly involves the external retinal segments. Retinal fluid is infrequent.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 24751654     DOI: 10.1159/000357980

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  6 in total

1.  A randomized trial of intravitreal bevacizumab vs. ranibizumab for myopic CNV.

Authors:  Alfredo Pece; Paolo Milani; Carla Monteleone; Costantino John Trombetta; Giuseppe De Crecchio; Giuseppe Fasolino; Domenica Matranga; Salvatore Cillino; Maria Vadalà
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-12-13       Impact factor: 3.117

2.  Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?

Authors:  Paolo Milani; Marco Pellegrini; Amedeo Massacesi; Stefania Moschini; Marco Setaccioli; Davide Soranna; Antonella Zambon; Ferdinando Bottoni; Fulvio Bergamini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-30       Impact factor: 3.117

3.  Long-term outcomes of myopic choroidal neovascularisation treated with combined ranibizumab and dexamethasone characterised by multi-modal imaging.

Authors:  Anna C S Tan; Kelvin Teo; Ong Sze Guan; Adrian Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-12       Impact factor: 3.117

Review 4.  Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy.

Authors:  Kelvin Yi Chong Teo; Wei Yan Ng; Shu Yen Lee; Chui Ming Gemmy Cheung
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

5.  Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians.

Authors:  Paolo Milani; Amedeo Massacesi; Stefania Moschini; Marco Setaccioli; Ennio Bulone; Gemma Tremolada; Stefano Ciaccia; Elena Mantovani; Daniela Morale; Fulvio Bergamini
Journal:  Clin Ophthalmol       Date:  2016-09-12

6.  Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization.

Authors:  Rui Gao; Jingxue Ma; Zhengwei Zhang; Qingli Shang; Jialiang Duan
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.